Joel C. Miller

Director, Statistical Operations
Everest Clinical Research, Little Falls, NJ, USA

Presentation(s):

• OC 01.2 - Improvements in Health-Related Quality of Life in Adults with Severe or Moderately Severe Hemophilia B After Receiving Etranacogene Dezaparvovec Gene Therapy

  Saturday, July 9, 2022
  1:15 PM – 1:30 PM